Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

OX40 Upregulation on CD4+ Central Memory T Cells in a Subset of Patients With Chronic Spontaneous Urticaria Correlates With Severity and Autoimmunity Features.

Created on 14 Nov 2026

Authors

Chuqiao Zhang, Minyang Zhang, Qingqing Jiao, Yujie Ding

Published in

Experimental dermatology. Volume 35. Issue 11.

Abstract

Chronic spontaneous urticaria (CSU) is a common, distressing skin disease driven by dysregulated immune responses. OX40 is a key costimulatory molecule implicated in Type 2 inflammation, yet the role of memory T cell subsets and the OX40/OX40L co-stimulatory axis in driving CSU pathogenesis remains poorly defined. To characterize the peripheral frequencies of memory T cell subsets and OX40 expression patterns in patients with CSU, and to explore their associations with disease activity and autoimmune features, this study comprised two parts. Part 1 was a retrospective cohort analysis including 110 patients with CSU, examining the relationship between memory T-cell subset frequencies and clinical parameters. Part 2 was a prospective nested case-control study including 30 age- and sex-matched CSU patients (overlapping with Part 1) and 30 healthy controls (HCs), utilizing flow cytometry to assess OX40 expression on T-cell subsets. Memory T cell subsets (naïve, central memory [TCM], effector memory [TEM]) and the percentages of OX40-positive cells were analysed by flow cytometry. Key clinical parameters, including disease activity (7-day Urticaria Activity Score, UAS7), health-related quality of life (Dermatology Life Quality Index, DLQI), and thyroid autoantibody levels, were evaluated. CSU patients showed an imbalanced memory T cell profile, with increased frequencies of CD4+ TEM and reduced frequencies of CD4+ TCM. The percentage of OX40-positive cells was significantly elevated on CD4+ TCM in CSU compared with HCs (p = 0.005) and positively correlated with disease severity (UAS7: rs = 0.574, p = 0.001), impaired health-related quality of life (DLQI: rs = 0.889, p < 0.001), and serum levels of thyroid peroxidase antibodies (TPOAb: rs = 0.418, p = 0.03). Our findings reveal dysregulated OX40 expression on memory T cells in CSU, linking it to disease severity and autoimmune features, thus identifying OX40 as a promising novel therapeutic target for patients with refractory CSU, especially those with autoimmune comorbidities.

PMID:
43031262
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement